In summary, we confirmed that the RFX5/STIL axis promoted HCC cell stemness by regulating aerobic glycolysis, suggesting that RFX5/STIL may serve as potential biomarkers in HCC. The gene discussed is RFX5; the disease is hepatocellular carcinoma.